AAIBA

 Jean Bousquet, born in 1946

• Professor of Pulmonary Medicine at Montpellier University, Montpellier, France (1991-2014)
• Professor of Allergology at Charité, Berlin, Germany (2016-current)
• Director of the Allergy Programme, Institut Pasteur, Paris, France (2001-2003)
• Director of the Inserm Unit 454 “Immunopathology of Asthma” (1992-2007)
• Coordinator of MeDALL (Mechanisms of the Development of Allergy), FP7 Integrated Project (2010-2014, FP7 success story)
• Chairman of the Allergen Standardization Committee (1990-1997), International Union of Immunological Societies (IUIS) and World Health Organization (WHO)
• Chairman of GINA (Global Initiative for Asthma: 1999-2000, National Heart, Lung and Blood Institute (NIH) and WHO)
• Founder and chairman of ARIA (Allergic Rhinitis and its Impact on Asthma) in collaboration with WHO (1999-current)
• Founder and chairman of the WHO Global Alliance against Chronic Respiratory Diseases (GARD, 2006-2013)
• Co-chair of the Reference Site Collaborative Network (RSCN) of the European Innovative Partnership on Active and Healthy Ageing (EIP on AHA) (DG Santé and DG CONNECT, 2016-2022).

Jean Bousquet has always combined research, clinical and public health interests. He performed translational research from a clinical observation in his clinic to the assessment of the disease burden (epidemiology), the understanding of the mechanisms, the implementation of the results to populations developing guidelines, national or international programmes and the deployment of the results with the EU or WHO. His research, initially focussing on allergens and immunotherapy (1980s), was then directed towards asthma (1990).  He confirmed inflammation in asthma (1990) and proposed and demonstrated the concept of airways remodelling in asthma (1992). He was a pioneer in allergy multimorbidity (1999) and proposed a new definition for allergic diseases (2015). He is now interested in the digital transformation of health with DG CONNECT and DG Santé, air pollution (POLLAR: Impact of air pollution on asthma and rhinitis, EIT Health), Climate Change (Horizon Europe grant) and Planetary Health.

Jean Bousquet

• Has edited and authored 10 books including one allergy textbook.
• Has been the author / co-author of over 1,000 peer-reviewed papers posted on Medline.
• Has an H factor of 139 (Clarivate) and 185 (Google Scholar). Three papers in Clarivate (first author) are cited over 2,000 times and 6 others over 1,000 times (2 as first author).
• Was listed as the most influential author in asthma (2018) and has published 5 of the 22 best cited papers in asthma (among the 190,000 papers published between 1960 and 2017, Qu et al, Respir Med, 2018, 137: 206-212).
• Was listed as one of the 800 most cited authors in all scientific fields among over 6.6 million researchers (Iaonidis et al, PLoS Biol. 2020 Oct 16;18(10):e3000918).
• Is listed as second immunologist in Europe, 19^th in the world and first in France (2023, com).
• Is the PI of the MASK-air^® app (a Best Practice of the Organisation of Economic Co-operation and Development (OECD, April, 2023) and a humanitarian app for Ukrainian refugees (Ministry of Health, Ukraine)).
• Has developed an app with a single question allowing house cleaners (ADMR) to participate in the health system in remote areas and reimbursed by French social services (Article 51).

He was the editor of European Respiratory Review and Allergy (second ranking journal in the field, 2003-2009, IF: 6.2). He is the editor of Clinical Translational Allergy (no IF in 2016, IF 2021: 5.85). 

Bióloga, Doctorada en Inmunología por la Universitat Autonoma de Barcelona. Postdoctoral en The Scripps Clinic Research Institute (California-USA)

Investigadora/jefe del Grupo de Enfermedades Inflamatorias, que incluye investigadores multidisciplinarios y estudiantes del Máster en Inmunología Avanzada. De la investigación traslacional realizada en los últimos años destacan más de 40 artículos y diversos proyectos competitivos, así como convenios-colaboración con la industria para caracterizar poblaciones celulares en líquidos biológicos complejos y analizar funcionalmente la respuesta inmune en pacientes con patologías inflamatorias y oncológicas, así como la búsqueda con aproximaciones novedosas de biomarcadores de diagnóstico y de respuesta a tratamientos inmunobiológicos.

Cargo actual y Centro de Trabajo:

• INVESTIGADORA , JEFE DE GRUPO ENFERMEDADES INFLAMATORIAS, INST. RECERCA HOSPITAL S. PAU, BARCELONA
• PROFESORA ASOCIADA INMUNOLOGIA, UNIVERSITAT AUTONOMA DE BARCELONA

Títulos y Formación:

• Médica. Universidad de Buenos Aires. UBA. 2006.
• Especialista en Medicina General/Familiar. 2009
• Referente en Patologías Mastocitarias: Instancia Formativa de Posgrado en el CLMAST: Hospital Virgen del Valle de Toledo, España. 2018
• Referente en Déficit DAO, Instancia formativa en el International Institute of DAO Deficiency, Barcelona. 2021.
• Desempeño asistencial: Centro de Hematología Pavlovsky, CABA.  Centro de Referencia en Mastocitosis y Patologías Mastocitarias en Latinoamérica.
• Miembro del AIM: American Initiative in Mast Cell Diseases, USA.

Actividades Docentes Actuales:

• Docente invitada de la Cátedra de Patologías Poco Frecuentes de la Carrera de Medicina de la Universidad Nacional de La Plata, UNLP: “Histaminosis y Síndrome de Activación Mastocitaria¨. Argentina.
• Docente del International Institute of DAO Deficiency. “Mastocitosis y Síndrome de Activación Mastocitaria”. España.
• Docente invitada de la Diplomatura de Alergias Alimentarias, Universidad Católica de Salta, “Intolerancia a la Histamina y Déficit DAO”. Argentina.
  
  

Ultimas Ponencias:

• III Jornadas Médicas sobre Patologías Mastocitarias. Asociación Española de Mastocitosis y Enfermedades Relacionadas. Caso Clínico: “De la Emergencia al difícil Diagnóstico de Mastocitosis en la Atención Primaria de la Salud”.2021. España.
• XLV Congreso Anual de la Asociación Argentina de Alergia e Inmunología Clínica,  2do. Premio para Trabajos Libres. Caso Clínico:“Síndrome de Activación Mastocitaria y Anafilaxias por picadura de Himenópteros.” Con el Servicio de Alergia e Inmunología del Htal. San Juan de Dios de La Plata. 2022, Bs. As. Argentina
• AIM Virtual Meeting of American Initiative in Mast Cell Diseases, Case: “When to think about Systemic Mastocytosis in children”. 2023. USA.
• XXIV Congreso Argentino de Hematología: “Mastocitosis: Actualización en Criterios Diagnósticos y cómo tratar causas Neoplásicas.” 2023. Mar del Plata.  Publicación Científica en la Revista Argentina de Hematología, Vol 27, p. 93-107. 2023
• 2024 Physician and Investigator Conference: American Initative in Mast Cell Diseases: “Case Reports: Cutaneous Mastocytosis, Advanced Systematic Mastocytosis and Hairy Cell Leukemia. What is their relationship?
• “Experience of patients with Mastocytosis in a Reference Center in Buenos Aires, Argentina: Pavlovsky Hematology Center”. 2024 Boston. USA.